Enalapril Pharmaceutical Reference Standards

Aligns Pharma science supply high-quality impurities reference standards of Enalapril, pharmacopeial and non-pharmacopeial Enalapril impurities, metabolites, stable isotope products, and nitrosamines (N-NO products). Enalapril impurities reference standards are useful in pharmaceutical research. They are useful in product development, ANDA and DMF filing, quality control (QC), method validation, and stability studies. It is also useful in the identification of unknown impurities and the assessment of genotoxic potential.

Enalapril Maleate which is an ACE inhibitor is administered in the form of Enalapril maleate. It is used for the treatment of of hypertension, diabetic nephropathy and chronic heart failure.

 

Our Enalapril impurities reference standard offering includes

  • Enalapril related products are thoroughly characterized with NMR, MASS, IR and HPLC/ GC purity.
  • Enalapril products are supplied with detailed COA & analytical data meeting regulatory compliance.
  • We can also provide Enalapril EP/USP traceable standards based on your requirements.
  • The supplied Enalapril related products are re-tested at regular intervals.

 

CAT No: APS-E00201
CAS No: 76095-16-4
Mol.F.: C20H28N2O5 : C4H4O4
Mol.Wt.: 376.5 : 116.1
Inv. Status: Inquire
CAT No: APS-E00202
CAS No: 76420-74-1
Mol.F.: C20H28N2O5
Mol.Wt.: 376.5
Inv. Status: Inquire
CAT No: APS-E00203
CAS No: 82717-96-2
Mol.F.: C15H21NO4
Mol.Wt.: 279.3
Inv. Status: Inquire
CAT No: APS-E00204
CAS No: 76420-72-9
Mol.F.: C18H24N2O5
Mol.Wt.: 348.4
Inv. Status: Inquire
CAT No: APS-E00205
CAS No: 115729-52-7
Mol.F.: C20H26N2O4
Mol.Wt.: 358.4
Inv. Status: Inquire
CAT No: APS-E00206
CAS No: 2292151-89-2
Mol.F.: C26H32N2O5
Mol.Wt.: 452.6
Inv. Status: Inquire
CAT No: APS-E00207
CAS No: 76391-34-9
Mol.F.: C22H32N2O5
Mol.Wt.: 404.5
Inv. Status: Inquire
CAT No: APS-E00208
CAS No: 460720-14-3
Mol.F.: C15H27NO4
Mol.Wt.: 285.4
Inv. Status: Inquire
CAT No: APS-E00209
CAS No: 2055735-10-7
Mol.F.: C20H34N2O5
Mol.Wt.: 382.5
Inv. Status: Inquire